Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Hyundai Motor (005380) – (Corrected) Decision on Convening General Meeting of Shareholders / 2026-03-05 Disclosures
  • [Disclosure] Celltrion (068270) – Share Retirement Decision / 2025-03-14 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders / 2025-12-16 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Amendment of Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea / 2026-03-30 Disclosures
  • [Disclosure] Samsung Electronics(005930) – Results of Annual General Meeting of Shareholders / 2024-03-20 Disclosures
  • [Disclosure] Jeju Semiconductor(080220) – Resolution on Convening of Extraordinary General Meeting of Shareholders / 2026-05-12 Disclosures
  • [Disclosure] Jusung Engineering(036930) – Investor Relations (IR) Presentation / 2024-02-02 Semiconductors
  • [Disclosure] Celltrion (068270) – Expiration of Part 1 Approval for Phase 3 Clinical Trial Plan of CT-P13 SC (Remsima Subcutaneous) in Europe Due to Development Strategy Change (Pediatric Crohn’s Disease) / 2026-06-18 Disclosures

[Disclosure] PSK Holdings (031980) – Submission of Audit Report / 2026-03-20

Posted on March 20, 2026August 5, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

PSK Holdings received and submitted an ‘Unqualified’ audit opinion from Shin-Han Accounting Corporation for both its consolidated and separate financial statements for FY2025.

📊 [Key Disclosure Details & Major Figures Summary]

  • External Auditor: Shin-Han Accounting Corporation (Audit Report Received: March 20, 2026)
  • Consolidated Financial Audit Opinion & Key Figures:
    • Audit Opinion: Unqualified (No uncertainty regarding going concern)
    • Revenue: KRW 207.76B (KRW 207,764,042,799 / YoY -3.59%)
    • Operating Profit: KRW 73.40B (KRW 73,400,914,769 / YoY -17.04%)
    • Profit Before Tax: KRW 107.27B (KRW 107,273,147,038)
    • Net Profit: KRW 91.68B (KRW 91,684,937,183 / YoY -4.32%)
    • Total Assets / Total Liabilities / Total Equity: KRW 584.88B / KRW 78.50B / KRW 506.38B
  • Separate Financial Audit Opinion & Key Figures:
    • Audit Opinion: Unqualified
    • Revenue: KRW 188.88B (KRW 188,876,147,986 / YoY +9.67%)
    • Operating Profit: KRW 68.12B (KRW 68,121,129,861 / YoY +17.76%)
    • Net Profit: KRW 63.42B (KRW 63,416,301,706 / YoY +27.24%)
    • Total Assets / Total Liabilities / Total Equity: KRW 368.19B / KRW 46.48B / KRW 321.71B
  • Financial Soundness Metrics: Capital Impairment Ratio (N/A), Loss Before Tax / Operating Loss (N/A), Impairment Loss Ratio over 50% (No)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Final Approved Financials in the Upcoming Annual Report

Since the financial statements in this audit report are subject to final approval at the Annual General Meeting of Shareholders, it is important to confirm whether any adjustments occur during the AGM approval process. The finalized financial figures and detailed notes can be cross-checked in the ‘Financial Statements’ and ‘Notes to Financial Statements’ sections of the upcoming ‘Annual Report’.

📢 Disclaimer & Source Notice

Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).

Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] Samsung Electronics (005930) – Exercise and Non-Exercise of Voting Rights by Trustee / 2026-03-20
Next Post: [Disclosure] Hanwha Systems (272210) – Results of Annual General Meeting of Shareholders (Correction) / 2026-03-23

Related Posts

  • [Disclosure] Hyundai Motor (005380) – (Correction) Decision on Acquisition of Shares and Equity Securities of Other Corporation / 2024-06-04 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Correction of Single Sales or Supply Contract / 2024-12-12 Disclosures
  • [Disclosure] SK Square (402340) – (Correction) Decision on Paid-in Capital Increase / 2026-07-10 Disclosures
  • [Disclosure] Celltrion (068270) – Provisional Consolidated Financial Results / 2025-02-25 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Acquisition of Shares and Equity Securities of Other Corporations / 2025-12-23 Disclosures
  • [Disclosure] SK square (402340) – Change in Revenues or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2026-02-10 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Holding / 2024-05-08 Semiconductors
  • [Disclosure] Jusung Engineering (036930) – Notice of New Listing of Stock Futures and Options (Listing of New Contract Months for Stock Futures Following Withdrawal of Corporate Spin-off) / 2024-11-14 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2025-04-24 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-04-30 Semiconductors
  • [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2026-04-30 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Provisional Consolidated Financial Performance (Fair Disclosure) / 2024-07-31 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Matters Related to Obligations of Timely Disclosure (Fair Disclosure) / 2024-07-26 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) New Facility Investment / 2024-12-18 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme